PamGene will be in Nancy on November 8, 2022 to present its new multiplex kinase activity profiling technology with applications in pathway elucidation and biomarker studies.
If you are interested in this technology, you can make an appointment for a presentation with Justin LEBENS by email: jlebens [at] pamgene.com (jlebens[at]pamgene[dot]com)
Summary: Kinases are the most intensively studied proteins in a wide variety of research fields. However, traditional approaches study the abundance of proteins rather than their activity. This results in a knowledge gap on how cell signaling really works. Here we present a functional assay and a novel technology that can predict kinases that are differentially active across conditions, leading to new insights and applications.